Becoming adherent to a preventive treatment for HIV: a qualitative approach.

Adult Anti-HIV Agents Double-Blind Method Focus Groups HIV Infections / prevention & control Humans Male Medication Adherence Pre-Exposure Prophylaxis Qualitative Research
HIV PrEP intake adherence coping strategies prevention qualitative methods stigmatization

Journal

Psychology, health & medicine
ISSN: 1465-3966
Titre abrégé: Psychol Health Med
Pays: England
ID NLM: 9604099

Informations de publication

Date de publication:
03 2020
Historique:
pubmed: 12 7 2019
medline: 27 10 2020
entrez: 12 7 2019
Statut: ppublish

Résumé

The clinical trial ANRS-IPERGAY investigated the efficacy of sexual activity-based (i.e. on demand) HIV pre-exposure prophylaxis (PrEP). Using a qualitative method, we analysed the role of adherence as one of the main elements for PrEP effectiveness and its associated determinants. Data were collected in various French ANRS-IPERGAY sites during the double-blind (2012-2014) and open-label study (2015-2016) phases, through two individual interviews per participant, collective interviews and focus groups. A total of 83 participants participated in the present study. Our analysis included 32 individual interviews (with 16 participants), 13 collective interviews (

Identifiants

DOI: 10.1080/13548506.2019.1640886 PMID: 31294630
pubmed: 31294630
doi: 10.1080/13548506.2019.1640886
doi:

Substances chimiques

Anti-HIV Agents 0

Types de publication

Journal Article Randomized Controlled Trial Research Support, Non-U.S. Gov't

Langues

eng

Sous-ensembles de citation

IM

Pagination

270-281

Auteurs

Costanza Puppo (C)

GRePS, Lyon 2 University, Lyon, France.

Xavier Mabire (X)

GRePS, Lyon 2 University, Lyon, France.

Stéphane Morel (S)

AIDES, Paris, France.

Vanessa Laguette (V)

CRPCO, Jules Verne University, Amiens, France.

Daniela Rojas Castro (D)

Coalition Plus, Paris, France.
INSERM, IRD, SESSTIM, Aix Marseille University, Marseille, France.

Julie Chas (J)

Hôpital Tenon, Paris, France.

Eric Cua (E)

Hôpital de l'Archet, Nice, France.

Claire Pintado (C)

Hôpital de l'Archet, Nice, France.
Hospital Saint-Louis, Department of Infectious Disease, Assistance Publique Hôpitaux de Paris, Paris, France.

Marie Suzan-Monti (M)

INSERM, IRD, SESSTIM, Aix Marseille University, Marseille, France.
ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Bruno Spire (B)

INSERM, IRD, SESSTIM, Aix Marseille University, Marseille, France.
ORS PACA, Southeastern Health Regional Observatory, Marseille, France.

Jean-Michel Molina (JM)

Hospital Saint-Louis, Department of Infectious Disease, Assistance Publique Hôpitaux de Paris, Paris, France.

Marie Préau (M)

GRePS, Lyon 2 University, Lyon, France.

Articles similaires

[Redispensing of expensive oral anticancer medicines: a practical application].

Lisanne N van Merendonk, Kübra Akgöl, Bastiaan Nuijen
1.00
Humans Antineoplastic Agents Administration, Oral Drug Costs Counterfeit Drugs

Smoking Cessation and Incident Cardiovascular Disease.

Jun Hwan Cho, Seung Yong Shin, Hoseob Kim et al.
1.00
Humans Male Smoking Cessation Cardiovascular Diseases Female

Evaluation of Low-Value Services Across Major Medicare Advantage Insurers and Traditional Medicare.

Ciara Duggan, Adam L Beckman, Ishani Ganguli et al.
1.00
Humans United States Aged Cross-Sectional Studies Medicare Part C

Effectiveness of Virtual Yoga for Chronic Low Back Pain: A Randomized Clinical Trial.

Hallie Tankha, Devyn Gaskins, Amanda Shallcross et al.
1.00
Humans Yoga Low Back Pain Female Male

Classifications MeSH

questionsmedicales.fr › Personnes › Tranches d'âge › Adulte › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Actions chimiques et utilisations › Actions pharmacologiques › Utilisations thérapeutiques › Anti-infectieux › Antiviraux › Antirétroviraux › Agents antiVIH › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Méthodologie en recherche épidémiologique › Méthode en double aveugle › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Méthodes épidémiologiques › Collecte de données › Groupes de discussion › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Maladies du système immunitaire › Déficits immunitaires › Infections à VIH › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Eucaryotes › Animaux › Chordés › Vertébrés › Mammifères › Eutheria › Primates › Haplorhini › Catarrhini › Hominidae › Humains › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Qualité, accès, évaluation des soins de santé › Prestations des soins de santé › Attitude envers la santé › Adhésion et observance thérapeutiques › Acceptation des soins par les patients › Observance par le patient › Adhésion au traitement médicamenteux › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Environnement et santé publique › Santé publique › Pratiques en santé publique › Prévention primaire › Prophylaxie pré-exposition › Becoming adherent to a preventive treatment...
questionsmedicales.fr › Disciplines des sciences naturelles › Science › Recherche › Recherche empirique › Recherche qualitative › Becoming adherent to a preventive treatment...